Prediction of Appearance of Late Cutaneous Side Effects After RadioTherapy (PAESCART)

Centre Francois Baclesse

Status: Completed

Conditions: Radiotherapy Side Effect; Merkel Carcinoma

Treatments: Diagnostic Test: blood sample

Study type: Interventional

Funder types: Other

Identifiers

NCT03060226

2016-A02021-50

Details and patient eligibility

About

Search for blood predictive marker (s) for cutaneous radiosensitivity

Enrollment: 18 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient treated with surgery and radiotherapy (RT) for histologically proven Merkel carcinoma
• Previous radiotherapy treatment completed for at least 6 months
• Absence of prior treatment by chemotherapy or hormonotherapy
• Patient over 18 years of age
• Patient affiliated to a social security system
• Informed consent signed

Exclusion criteria

• Presence of another evolutionary cancer
• Re-irradiation in the same area
• Absence of available dosimetry data
• Patient under guardianship or curatorship or safeguard of justice

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

18 participants in 2 patient groups

Control group

Other group

Treatment:

Diagnostic Test: blood sample

radiosensibility group

Other group

Treatment:

Diagnostic Test: blood sample